Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-32,800
Closed -$817K 1619
2025
Q4
$817K Buy
+32,800
New +$827K 0.02% 353
2025
Q2
Sell
-39,700
Closed -$1.01M 1225
2025
Q1
$1.01M Buy
+39,700
New +$1.04M 0.03% 266

Other funds holding PFE

DRW Securities's PFE Position: Q1 2026 in Review

DRW Securities reduced its Pfizer (PFE) stake by 23% in Q1 2026, selling an estimated $177K and leaving 22,683 shares worth $637K. The position accounts for 0.01% of the portfolio, ranked #504.

DRW Securities first reported a position in PFE in Q2 2013 and has held it in 17 quarters since. The position peaked at $3.71M in Q4 2015. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • DRW Securities held 22,683 shares of Pfizer worth $637K as of Q1 2026.
  • DRW Securities sold 6,632 Pfizer shares in Q1 2026, an estimated $177K.
  • Pfizer made up 0.01% of DRW Securities's portfolio in Q1 2026, its #504 holding.
  • DRW Securities first reported a position in Pfizer in Q2 2013 and has held it in 17 quarters since.
  • DRW Securities's Pfizer position peaked at $3.71M in Q4 2015.
  • 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on DRW Securities's 13F filing for Q1 2026, filed 13 May 2026.